Skip to main navigation Skip to search Skip to main content

Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF 301 trial

  • Shalini Makawita
  • , Ghassan K Abou-Alfa
  • , Sameek Roychowdhury
  • , Saeed Sadeghi
  • , Ivan Borbath
  • , Lipika Goyal
  • , Allen Cohn
  • , Angela Lamarca
  • , Do Youn Oh
  • , Teresa MacArulla
  • , Rachna T Shroff
  • , Michael Howland
  • , Ai Li
  • , Terry Cho
  • , Amit Pande
  • , Milind Javle

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF 301 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science